Loading…
Medicover AB committed to acquire shares from existing shareholders to increase its ownership in NIPD Genetics from 18.9% to 87.2%. The purchase price for the 68.3% stake is EUR 44.4 million, implying an enterprise value of EUR 65.0 million.